Aim Immunotech shares owned by Bridgeway Capital Management
Quarter-by-quarter ownership of Aim Immunotech (AIM) shares owned by Bridgeway Capital Management
from 13F filings
Historical chart of Bridgeway Capital Management investment in Aim Immunotech
Tip: Access up to 7 years of quarterly data
All positions including Aim Immunotech held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aim Immunotech by Bridgeway Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $51k | 109k | 0.47 |
| 2023-09-30 | $50k | 109k | 0.46 |
| 2023-06-30 | $73k | 109k | 0.67 |
| 2023-03-31 | $47k | 109k | 0.43 |
| 2022-12-31 | $47k | 151k | 0.31 |
| 2022-09-30 | $88k | 151k | 0.58 |
| 2022-06-30 | $118k | 151k | 0.78 |
| 2022-03-31 | $171k | 161k | 1.06 |
| 2021-12-31 | $199k | 216k | 0.92 |
| 2021-09-30 | $477k | 236k | 2.02 |
| 2021-06-30 | $529k | 246k | 2.15 |
| 2021-03-31 | $615k | 271k | 2.27 |
| 2020-12-31 | $199k | 111k | 1.79 |
More positions owned by Bridgeway Capital Management
View all positions for Bridgeway Capital Management